- Ecuador vice president says Noboa seeking her 'banishment'
- Leicester boss Van Nistelrooy aware of 'bigger picture' as Liverpool await
- Syria authorities say armed groups have agreed to disband
- Maresca expects Man City to be in title hunt as he downplays Chelsea's chancs
- Man Utd boss Amorim vows to stay on course despite Rashford row
- South Africa opt for all-pace attack against Pakistan
- Guardiola adamant Man City slump not all about Haaland
- Global stocks mostly higher in thin pre-Christmas trade
- Bethlehem marks sombre Christmas under shadow of war
- NASA probe makes closest ever pass by the Sun
- 11 killed in blast at Turkey explosives plant
- Indonesia considers parole for ex-terror chiefs: official
- Global stocks mostly rise in thin pre-Christmas trade
- Postecoglou says Spurs 'need to reinforce' in transfer window
- Le Pen says days of new French govt numbered
- Global stocks mostly rise after US tech rally
- Villa boss Emery set for 'very difficult' clash with Newcastle
- Investors swoop in to save German flying taxi startup
- How Finnish youth learn to spot disinformation
- South Korean opposition postpones decision to impeach acting president
- 12 killed in blast at Turkey explosives plant
- Panama leaders past and present reject Trump's threat of Canal takeover
- Hong Kong police issue fresh bounties for activists overseas
- Saving the mysterious African manatee at Cameroon hotspot
- India consider second spinner for Boxing Day Test
- London wall illuminates Covid's enduring pain at Christmas
- Poyet appointed manager at South Korea's Jeonbuk
- South Korea's opposition vows to impeach acting president
- The tsunami detection buoys safeguarding lives in Thailand
- Teen Konstas to open for Australia in Boxing Day India Test
- Asian stocks mostly up after US tech rally
- US panel could not reach consensus on US-Japan steel deal: Nippon
- The real-life violence that inspired South Korea's 'Squid Game'
- Blogs to Bluesky: social media shifts responses after 2004 tsunami
- Tennis power couple de Minaur and Boulter get engaged
- Supermaxi yachts eye record in gruelling Sydney-Hobart race
- Hawaii's Kilauea volcano erupts, spewing columns of lava
- MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
- The Glimpse Group Regains Compliance with NASDAQ
- Sokoman Minerals Completes Phase 1 Diamond Drilling Program Fleur de Lys Gold Project, NW Newfoundland
- Canadian Government Provides C$100 Million Financing LOI to Green Technology Metals in Support of Electric Royalties' Flagship Lithium Royalty Asset in Ontario
- Sendero Resources Announces First Tranche Closing of Its Non-Brokered Private Placement
- EVSX Completes Installation of Multi Chemistry Line
- InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 24
- El Salvador Congress votes to end ban on metal mining
- Five things to know about Panama Canal, in Trump's sights
- NBA fines Minnesota guard Edwards $75,000 for outburst
- Haitians massacred for practicing voodoo were abducted, hacked to death: UN
- Inter beat Como to keep in touch with leaders Atalanta
- Mixed day for global stocks as market hopes for 'Santa Claus rally'
'Synthetic embryo' breakthrough but growing human organs far off
Stem cell scientists say they have created "synthetic embryos" without using sperm, eggs or fertilisation for the first time, but the prospect of using such a technique to grow human organs for transplantation remains distant.
The breakthrough was hailed as a major step forward, though some experts said the result could not fully be considered to be embryos and warned of future ethical considerations.
In research published in the journal Cell this week, scientists at the Weizmann Institute of Science in Israel described mouse stem cells self-assembling into embryo-like structures in the lab.
The research built upon 2018 research that had a bundle of mouse stem cells self-organised into something resembling the beginnings of an embryo -- but with far fewer cells.
The Weizmann team led by Palestinian stem cell scientist Jacob Hanna went much further.
They started by collecting cells from the skin of mice, then made them artificially return to the state of stem cells.
The stem cells were then placed in a special incubator, which continuously moved to mimic a mother's womb.
The vast majority of the cells failed to form anything.
But 50 -- 0.5 percent of the 10,000 total -- collected themselves into spheres, then embryo-like structures, the researchers said.
After eight days -- around a third of the 20-day mouse gestation period -- there were early signs of a brain and a beating heart, they added.
They were described as 95 percent similar to normal mouse embryos.
"The embryo is the best organ-making machine and the best 3D bioprinter -- we tried to emulate what it does," Hanna said in a Weizmann statement.
- 'Not embryos' -
While they were the most advanced synthetic embryo-like structures ever grown, some scientists not involved in the research warned against calling them "embryos".
"These are not embryos," French stem cell scientist Laurent David told AFP.
"Until proven otherwise, they do not result in a viable individual capable of reproducing," he added.
He preferred to call them embryoids, the name for a group of cells that resemble an embryo, emphasising that they showed only the very beginnings of organs.
However, David welcomed the "very convincing" research, which he said could allow further experiments to understand exactly how organs form.
Hanna said the team's "next challenge is to understand how stem cells know what to do -- how they self-assemble into organs and find their way to their assigned spots inside an embryo".
- Ethical implications -
If human organs could one day be grown in a lab, it could provide life-saving transplants to thousands of people every year without the need for donors.
There has been progress in this new field -- several years ago researchers managed to develop an artificial intestine in the lab that could be implanted into a mouse.
For humans, however, such organ implants remain science fiction.
Still, Hanna has founded a company, Renewal Bio, that aims to find a way to use the technology for therapeutic purposes.
Researchers not involved in the study said it was very early to consider using such a technique for humans.
Alfonso Martinez Arias of Spain's Pompeu Fabra University said the breakthrough "opens the door to similar studies with human cells, though there are many regulatory hoops to get through first and, from the point of view of the experiments, human systems lag behind mouse systems".
And aiming to get similar results from human cells will likely open an ethical can of worms.
"Although the prospect of synthetic human embryos is still distant, it will be crucial to engage in wider discussions about the legal and ethical implications of such research," James Briscoe of Britain's Francis Crick Institute said.
H.E.Young--AMWN